Skip to main content

SGLT2 inhibitor ertugliflozin shows no CV death or renal benefit

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
SGLT2 inhibitor ertugliflozin shows no CV death or renal benefit

User login

Username

Password

Reset your password

Type	Lead	score